Comparison of effects of topical ibopamine and epinephrine on the circadian rhythm of intraocular pressure of the rabbit eye as measured by telemetry

Journal of Ocular Pharmacology and Therapeutics

Volumn 15, Issue 2, 1999, Pages 107-116

  McLaren, Jay W ^a   Bachman, Lori A ^a   Brubaker, Richard F ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; DRUG METABOLITE; EPININE; IBOPAMINE;

ANIMAL EXPERIMENT; AQUEOUS HUMOR FLOW; ARTICLE; CIRCADIAN RHYTHM; DRUG EFFECT; DRUG STRUCTURE; INTRAOCULAR HYPOTENSION; INTRAOCULAR PRESSURE; NONHUMAN; RABBIT; STRUCTURE ACTIVITY RELATION; TELEMETRY; TOPICAL DRUG ADMINISTRATION; TRANSDUCER;

EID: 0032915342     PISSN: 10807683     EISSN: None     Source Type: Journal    
DOI: 10.1089/jop.1999.15.107     Document Type: Article

References (24)

1. Dei Cas, L., Manca, C., Mansour, M., Vasini, G., Zonca, A., and Bernardini, B. Preliminary results of the action of long-term oral treatment with the di-isobutyric ester of N-methyldopamine (SB 7505) in 10 patients with severe cardiocirculatory decompensation. Boll. della Soc. Ital. di Cardiol. 25:593-600, 1980.
2. de Mey, C., Enterling, D., Brendel, E., and Wesche, H. Pharmacokinetics and pharmacodynamics of single oral doses of ibopamine, quinidine and their combination in normal man. Eur. J. Clin. Pharmacol. 34:415-418, 1988.
3. Casagrande, C., Merlo, L., Ferrini, R., Miragoli, G., and Semeraro, C. Cardiovascular and renal action of dopaminergic prodrugs. J. Cardiovasc. Pharmacol. 14(Suppl. 8):S40-59, 1989.
4. Itoh, H. Clinical pharmacology of ibopamine. Am. J. Med. 90:36S-42S, 1991.
5. Daul, A., Elter-Schulz, M., Poller, U., Jockenhovel, F., Ponicke, K., Boomsma, F., Man in't Veld, A.J., Schafes, R.F., and Brodde, O.E. Dose-dependent separation of dopaminergic and adrenergic effects of epinine in healthy volunteers. Naunyn-Schmiedebergs Arch. Pharmacol. 352:429-437, 1995.
6. Spencer, C., Faulds, D., and Fitton, A. Ibopamine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in congestive heart failure. Drugs & Aging 3:556-584, 1993.
7. Henwood, J.M. and Todd, P.A. Ibopamine. A preliminary review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy. Drugs 36:11-31, 1988.
8. Gelmi, C., Palazzuolo, A., Lucchetti, M., and Trimarchi, F. Pupillographic evaluation of the mydriatic effect of ibopamine solution. Int. J. Clin. Pharmacol. Therap. Toxicol. 27:346-351, 1989.
9. Micieli, G., Tassorelli, C., Iannacchero, R., Lodola, E., Barbieri, P., and Nappi, G. Dynamic evaluation by TV-pupillometry of the mydriatic effect of ibopamine solution. Controlled studies. Arzneimittel-Forschung 40(2 Part 1):150-156, 1990.
10. Drago, F., Dal Bello, A., Marino, V., Pisati, R., Lodola, E., and Barbieri, P. Evaluation of the effect of thymoxamine solution 0.5% on mydriasis induced by ibopamine solution 1%. Eur. J. Clin. Pharmacol. 44:477-480, 1993.
11. Potter, D.E., Burke, J.A., and Chang, F.W. Alteration in ocular function induced by phenylethylamine analogs of dopamine. Curr. Eye Res. 3:851-859, 1984.
12. De Gregorio, F., Pecori-Giraldi, J., De Stefano, C., and Virno, M. Correlation between ocular hypertension induced by ibopamine and perimetric defect in primary open-angle glaucoma. Eur. J. Ophthalmol. 7:152-155, 1997.
13. Virno, M., Percori-Giraldi, J., Taverniti, L., Taloni, M., and Pannarale, L. Intraocular hypertensive effects of topically administered ibopamine in eyes with hydrodynamic disorders: A new provocative test for glaucoma. Glaucoma 12:88-92, 1990.
14. Virno, M., Gazzaniga, A., Taverniti, L., Pecori Giraldi, J., and De Gregorio, F. Dopamine, dopaminergic drugs and ocular hypertension. Int. Ophthalmol. 16:349-353, 1992.
15. Virno, M., Taverniti, L., De Gregorio, F., Sedran, L., and Longo, F. Increase in aqueous humor production following D1 receptors activation by means of ibopamine. Int. Ophthalmol. 20:141-146, 1996-1997.
16. Virno, M., De Gregorio, F., Pannarale, L. and Arrico, L. Topical ibopamine and corticosteroids in the treatment of post-surgery ocular hypotony. Int. Ophthalmol 20:147-150, 1996-1997.
17. De Gregorio, F., Pecori Giraldi, J., Pannarale, L., Saccucci, S., and Virno, M. Ibopamine in glaucoma diagnostics: a new pharmacological provocative test. Int. Ophthalmol. 20:151-155, 1996-1997.
18. McLaren, J.W., Brubaker, R.F., and FitzSimon, J.S. Continuous measurement of intraocular pressure in rabbits by telemetry. Invest. Ophthalmol. Vis. Sci. 37:966-975, 1996.
19. Schnell, C.R., Debon, C., and Percicot, C.L. Measurement of intraocular pressure by telemetry in conscious, unrestrained rabbits. Invest. Ophthalmol. Vis. Sci. 37:958-965, 1996.
20. Rowland, J.M., Potter, D.E., and Reiter, R.J. Circadian rhythm in intraocular pressure: A rabbit model. Curr. Eye Res. 1:169-173, 1981.
21. Innemee, H.C. and van Zwieten, P.A. An increase in intraocular pressure due to clonidine. Graefes Arch. Klin. Exp. Ophthalmol. 207:149-156, 1978.
22. Maus, T.L. and Brubaker, R.F. Measurement of aqueous humor flow by fluorophotometry in the presence of a dilated pupil. Submitted to Invest. Ophthalmol. Vis. Sci.
23. Kacere, R.D., Dolan, J.W., and Brubaker, R.F. Intravenous epinephrine stimulates aqueous formation in the human eye. Invest. Ophthalmol. Vis. Sci. 33:2861-2865, 1992.
24. Townsend, D.J. and Brubaker, R.F. Immediate effect of epinephrine on aqueous formation in the normal human eye as measured by fluorophotometry. Invest. Ophthalmol. Vis. Sci. 19:256-266, 1980.